| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 143,4 k € | +11.5% | 128,6 k € | -12.3% | 146,6 k € | +14.7% | 127,8 k € | +143.5% | 52,5 k € | -43.7% | 93,2 k € | -6.4% | 99,6 k € | -13.2% | 114,7 k € | -3.5% | 118,9 k € | +14.9% | 103,4 k € | -6.0% | 110,0 k € | -5.6% | 116,6 k € | -13.6% | 134,9 k € | +59.2% | 84,7 k € | +370.0% | 18,0 k € | -56.3% | 41,3 k € | +48.1% | 27,9 k € | +38.0% | 20,2 k € | +139.8% | 8,4 k € | |
| EBITDA | 128,8 k € | +10.3% | 116,7 k € | -20.2% | 146,3 k € | +14.7% | 127,5 k € | +144.5% | 52,1 k € | -43.8% | 92,8 k € | -6.4% | 99,2 k € | -13.2% | 114,3 k € | -1.5% | 116,1 k € | +13.0% | 102,7 k € | -6.6% | 110,0 k € | -5.3% | 116,2 k € | -13.5% | 134,3 k € | +59.0% | 84,5 k € | +376.1% | 17,7 k € | -54.1% | 38,7 k € | +38.7% | 27,9 k € | +39.6% | 20,0 k € | +158.5% | 7,7 k € | |
| Operating profit | 71,9 k € | +20.1% | 59,9 k € | -33.1% | 89,4 k € | +26.6% | 70,6 k € | +39.7% | 50,5 k € | -44.6% | 91,2 k € | -6.6% | 97,6 k € | -13.4% | 112,7 k € | -1.6% | 114,5 k € | +13.2% | 101,1 k € | -6.7% | 108,4 k € | -6.7% | 116,2 k € | -13.5% | 134,3 k € | +63.7% | 82,0 k € | +436.3% | 15,3 k € | -57.8% | 36,2 k € | +29.9% | 27,9 k € | +39.6% | 20,0 k € | +158.5% | 7,7 k € | |
| Profit/loss | 52,9 k € | +55.6% | 34,0 k € | -22.3% | 43,8 k € | -7.4% | 47,3 k € | +34.1% | 35,3 k € | -51.2% | 72,2 k € | +3.7% | 69,7 k € | +1.9% | 68,4 k € | +2.2% | 66,9 k € | -2.9% | 68,9 k € | -3.8% | 71,6 k € | -9.0% | 78,7 k € | -12.5% | 89,9 k € | +74.7% | 51,5 k € | +380.5% | 10,7 k € | -53.4% | 23,0 k € | +45.9% | 15,8 k € | +18.6% | 13,3 k € | +230.6% | 4,0 k € | |
| Equity | 1,9 M € | +2.9% | 1,8 M € | +1.9% | 1,8 M € | +2.5% | 1,8 M € | +177.8% | 635,2 k € | +2.5% | 619,9 k € | +7.3% | 577,7 k € | +13.7% | 508,0 k € | +9.3% | 464,7 k € | +9.9% | 422,8 k € | +11.6% | 378,9 k € | +23.3% | 307,3 k € | +34.4% | 228,6 k € | +64.8% | 138,7 k € | +59.0% | 87,3 k € | +14.0% | 76,6 k € | +43.0% | 53,6 k € | +41.7% | 37,8 k € | +54.3% | 24,5 k € | |
| Total assets | 1,9 M € | +2.8% | 1,9 M € | +1.7% | 1,9 M € | +2.1% | 1,8 M € | +174.9% | 662,8 k € | -4.0% | 690,7 k € | +9.3% | 632,0 k € | +7.4% | 588,5 k € | +6.4% | 553,0 k € | +16.6% | 474,1 k € | +20.5% | 393,4 k € | -3.2% | 406,5 k € | +65.2% | 246,0 k € | +42.8% | 172,3 k € | +76.8% | 97,5 k € | +5.7% | 92,2 k € | +64.9% | 55,9 k € | +33.4% | 41,9 k € | -20.1% | 52,5 k € | |
| Cash | — | 232,0 k € | +39.5% | 166,3 k € | +52.8% | 108,8 k € | -82.2% | 612,5 k € | +18.7% | 516,1 k € | +61.8% | 319,0 k € | +61.5% | 197,5 k € | -32.4% | 292,1 k € | +406.0% | 57,7 k € | -56.0% | 131,1 k € | -44.7% | 237,0 k € | +191.7% | 81,2 k € | +72.3% | 47,2 k € | -41.6% | 80,7 k € | +620.1% | 11,2 k € | -28.1% | 15,6 k € | +885.5% | 1,6 k € | -95.1% | 32,2 k € | ||
| Debts | 48,9 k € | -0.8% | 49,4 k € | -4.4% | 51,6 k € | -10.0% | 57,4 k € | +107.6% | 27,6 k € | -60.9% | 70,7 k € | +30.3% | 54,3 k € | -32.6% | 80,5 k € | -8.8% | 88,3 k € | +72.0% | 51,3 k € | +252.9% | 14,5 k € | -85.3% | 99,2 k € | +470.8% | 17,4 k € | -48.2% | 33,6 k € | +229.2% | 10,2 k € | -34.8% | 15,6 k € | +558.3% | 2,4 k € | -42.7% | 4,1 k € | -85.2% | 28,0 k € | |
Private limited company · Forest · incorporated on 29/10/1981
Private limited company profitable and well capitalised. Cash position rising (+39.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Laboratoires Biogam is a Private limited company incorporated in 1981. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Forest.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette